Search results
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 2 days agoStrategic Developments and Future Outlook Moderna's CEO, Stephane Bancel, emphasized the company's...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 2 days agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 2 days agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 2 days agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights
Guru Focus· 2 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Moderna Inc (MRNA, Financial) reported substantial clinical progress with ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 2 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 2 days agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company’s first quarter ...
Biotech’s bind over China bill
Politico· 21 hours agoMODERNA BULLISH ON RSV SHOT — Moderna executives signaled confidence Thursday that the drugmaker’s RSV vaccine can compete with shots already on the market ...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
FOX 59 Indianapolis· 3 days ago(CSE: BIOV) (OTCQB: BVAXF), Moderna, Inc. (NASDAQ: MRNA), Boundless Bio, Inc. (NASDAQ: BOLD),...